ICU Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
615.0K
+24.2%
495.0K
+17.9%
420.0K
+129.5%
183.0K
-45.9%
338.0K
Cost of Revenue
54.0K
+17.4%
46.0K
+283.3%
12.0K
-14.3%
14.0K
-48.1%
27.0K
Gross Profit
561.0K
+24.9%
449.0K
+10.0%
408.0K
+141.4%
169.0K
-45.7%
311.0K
Operating Expenses
4.4M
+7.4%
4.1M
+18.3%
3.4M
-8.6%
3.7M
+81.3%
2.1M
R&D
2.5M
+7.5%
2.3M
+6.5%
2.2M
+18.9%
1.9M
+78.4%
1.0M
SG&A
1.8M
+7.3%
1.7M
+39.5%
1.2M
-35.5%
1.9M
+84.3%
1.0M
Operating Income
-3791000
-5.2%
-3603000
-19.5%
-3016000
+15.7%
-3579000
-103.8%
-1756000
EBITDA
-3791000
-5.2%
-3603000
-19.5%
-3016000
+15.7%
-3579000
-103.8%
-1756000
Net Income
-3730000
-5.9%
-3521000
-21.2%
-2904000
+16.4%
-3472000
-73.4%
-2002000
EPS (Basic)
$-0.91
-1.1%
$-0.90
—
$-1.30
+26.6%
$-1.77
EPS (Diluted)
$-0.91
-1.1%
$-0.90
—
$-1.30
+26.6%
$-1.77
Shares (Diluted)
4.1M
+4.2%
3.9M
—
2.6M
+133.0%
1.1M
SeaStar Medical (ICU) — Financials